DRUG · Unmapped registry intervention
Certolizumab pegol (CZP)
Find medicine records ·
Find other trials using this name
Clinical trial
Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis
NCT00717236
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedCertolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
PlaceboOTHER
Sponsors & collaborators
UCB Pharmalead sponsor
Mapped research locations
New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1TorontoOntario, Canada1San AntonioTexas, United States1MadridSpain1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00717236 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.